Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 6
54
Views
0
CrossRef citations to date
0
Altmetric
Case Studies

Acute interstitial pneumonia due to amyopathic dermatomyositis

, MSORCID Icon, , MD, , MD & , MD
Pages 860-862 | Received 07 Jun 2022, Accepted 01 Aug 2022, Published online: 23 Aug 2022

  • Hall JC, Casciola-Rosen L, Samedy LA, et al. Anti–melanoma differentiation–associated protein 5–associated dermatomyositis: Expanding the clinical spectrum. Arthritis Care Res (Hoboken). 2013;65(8):1307–1315. doi:10.1002/acr.21992.
  • Selva-O'Callaghan A, Pinal-Fernandez I, Trallero-Araguás E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol. 2018;17(9):816–828. doi:10.1016/S1474-4422(18)30254-0.
  • Chen Z, Cao M, Plana MN, et al. Utility of anti–melanoma differentiation–associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res (Hoboken). 2013;65(8):1316–1324. doi:10.1002/acr.21985.
  • Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52(5):1571–1576. doi:10.1002/art.21023.
  • Bailey EE, Fiorentino DF. Amyopathic dermatomyositis: definitions, diagnosis, and management. Curr Rheumatol Rep. 2014;16(12):465. doi:10.1007/s11926-014-0465-0.
  • Jablonski R, Bhorade S, Strek ME, Dematte J. Recognition and management of myositis-associated rapidly progressive interstitial lung disease. Chest. 2020;158(1):252–263. doi:10.1016/j.chest.2020.01.033.
  • González-Moreno J, Raya-Cruz M, Losada-Lopez I, Cacheda AP, Oliver C, Colom B. Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review. Rheumatol Int. 2018;38(7):1293–1296. doi:10.1007/s00296-018-3991-7.
  • Vuillard C, Pineton de Chambrun M, de Prost N, et al. Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study. Ann Intensive Care. 2018;8(1):87. doi:10.1186/s13613-018-0433-3.
  • Romero-Bueno F, Diaz del Campo P, Trallero-Araguás E, et al. Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease. Semin Arthritis Rheum. 2020;50(4):776–790. doi:10.1016/j.semarthrit.2020.03.007.
  • Rubin J, Black KE, Hallowell RW, et al. Veno-venous extracorporeal membrane oxygenation for myositis-associated rapidly progressive interstitial lung disease. Chest. 2021;160(6):2163–2167. doi:10.1016/j.chest.2021.06.075.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.